siopen.org
News
http://www.siopen.org/news-events
International Society of Paediatric Oncology Europe Neuroblastoma. What is a clinical trial? G-CSF in induction for high risk disease. Myeloablative therapy (BuMel vs CEM). The membership of the SIOPEN Executive Committee changed at the SIOPEN AGM in October 2014. Please see the relevant sections under 'About SIOPEN' for more information. The SIOPEN Spring Meeting 2015 will be held in Dublin, Ireland on 22-24 April. Further details to follow. The 2014 SIOPEN AGM will take place in Vienna 8-10 October 2014.
siopen.org
Myeloablative therapy (BuMel vs CEM)
http://www.siopen.org/siopen-studies/completed/mat
International Society of Paediatric Oncology Europe Neuroblastoma. What is a clinical trial? G-CSF in induction for high risk disease. Myeloablative therapy (BuMel vs CEM). Myeloablative therapy (BuMel vs CEM). Myeloablative chemotherapy: BuMel versus CEM. In the most recent SIOPEN High-Risk neuroblastoma study, two different combinations of myeloablative (high-dose) chemotherapy were compared. Link to abstract presented at ASCO Annual Meeting 2011. What is a clinical trial? Berlin (Germany): AGM 2017.
siopen.org
Opsoclonus/myoclonus
http://www.siopen.org/siopen-studies/current/oms
International Society of Paediatric Oncology Europe Neuroblastoma. What is a clinical trial? G-CSF in induction for high risk disease. Myeloablative therapy (BuMel vs CEM). What is a clinical trial? Lausanne (Switzerland): 5-7 October 2016 (AGM) registration for SIOPEN members is available here. Genova (Italy): 5-7 April 2017 (dates provisional, Spring meeting). Berlin (Germany): AGM 2017.
siopen.org
Neuroblastoma
http://www.siopen.org/neuroblastoma
International Society of Paediatric Oncology Europe Neuroblastoma. What is a clinical trial? G-CSF in induction for high risk disease. Myeloablative therapy (BuMel vs CEM). Is the most common solid cancer in children after brain tumours. Radiotherapy, differentiation therapy. MRI and CT scans. Links to more information. Institut de cancerologie Gustave Roussy. National Cancer Institute (USA). Associazione Italiana per la Lotta al Neuroblastoma. Berlin (Germany): AGM 2017. SIOPEN Verein zur Foderung der N...
siopen.org
G-CSF in induction for high risk disease
http://www.siopen.org/siopen-studies/completed/g-csf-in-induction
International Society of Paediatric Oncology Europe Neuroblastoma. What is a clinical trial? G-CSF in induction for high risk disease. Myeloablative therapy (BuMel vs CEM). G-CSF in induction for high risk disease. G-CSF in induction for high risk disease. In the HR-NBL/SIOPEN study, 239 patients with neuroblastoma in 16 countries were randomly assigned to receive or not receive prophylactic. During induction chemotherapy with rapid COJEC. The results showed that patients receiving G-CSF. This website ma...
siopen.org
Antibody infusion
http://www.siopen.org/siopen-studies/current/antibody
International Society of Paediatric Oncology Europe Neuroblastoma. What is a clinical trial? G-CSF in induction for high risk disease. Myeloablative therapy (BuMel vs CEM). Long-term antibody Infusion study. This is an early-phase clinical trial for patients with refractory. Not responding to initial treatment) or relapsed neuroblastoma. Patients will receive a combination of anti- GD2. What is a clinical trial? Genova (Italy): 5-7 April 2017 (dates provisional, Spring meeting). Berlin (Germany): AGM 2017.
neuroblastoma.org.uk
The Neuroblastoma Society becomes NEUROBLASTOMA UK — Neuroblastoma UK
http://www.neuroblastoma.org.uk/news/the-neuroblastoma-society-becomes-neuroblastoma-uk
Annual Review and Accounts. Friends of Neuroblastoma UK. Other Ways to Help. Contact Us on 020 8940 4353. Annual Review and Accounts. Friends of Neuroblastoma UK. Other Ways to Help. Contact Us on 020 8940 4353. October 29, 2015. The Neuroblastoma Society becomes NEUROBLASTOMA UK. October 29, 2015. The Neuroblastoma Society becomes NEUROBLASTOMA UK. October 29, 2015. The eagle-eyed among you will have noticed that we have changed our name but only slightly! We have had many lengthy discussions with our T...
neuroblastoma.org.uk
New Parent Booklet — Neuroblastoma UK
http://www.neuroblastoma.org.uk/families/booklet
Annual Review and Accounts. Friends of Neuroblastoma UK. Other Ways to Help. Contact Us on 020 8940 4353. Annual Review and Accounts. Friends of Neuroblastoma UK. Other Ways to Help. Contact Us on 020 8940 4353. March 1, 2016. March 1, 2016. March 1, 2016. Written by Dr Gail Halliday, Dr Sally George, Dr Daniel Morgenstern, Professor Deborah Tweddle and Dr Kate Wheeler on behalf of the CCLG Neuroblastoma Special Interest Group and produced in conjunction with Neuroblastoma UK and the CCLG Publications Co...
siopen.org
Low/intermediate risk
http://www.siopen.org/siopen-studies/current/lines
International Society of Paediatric Oncology Europe Neuroblastoma. What is a clinical trial? G-CSF in induction for high risk disease. Myeloablative therapy (BuMel vs CEM). The LINES study is for patients with low or intermediate risk disease. Patients with high-risk neuroblastoma will typically be treated on a separate high-risk study. The study is seeking to achieve a number of different things. For other patients believed to have particularly low risk disease (infants with localised unresectable.